![]() |
Volumn 25, Issue 3, 2014, Pages 267-269
|
TherapeuTic opportunities for medulloblastoma come of age
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MYCN PROTEIN;
PROTEIN;
PROTEIN P53;
PROTEIN PATCHED 1;
SMOOTHENED PROTEIN;
SONIC HEDGEHOG PROTEIN;
SUFO PROTEIN;
SUFU PROTEIN;
TRANSCRIPTION FACTOR GLI2;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PROTEIN KINASE B;
PROTEIN KINASE B INHIBITOR;
S6 KINASE;
AGE DISTRIBUTION;
CANCER MORTALITY;
CANCER SURVIVAL;
CELL GRANULE;
CELL PROLIFERATION;
CHILDHOOD MORTALITY;
GENE AMPLIFICATION;
GENE MUTATION;
HUMAN;
MEDULLOBLASTOMA;
NEUROTOXICITY;
PRIORITY JOURNAL;
SHORT SURVEY;
BONE GROWTH;
CRANIOSPINAL IRRADIATION;
IMMUNOHISTOCHEMISTRY;
PRACTICE GUIDELINE;
ANIMALS;
CLONAL EVOLUTION;
GENETIC VARIATION;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
ERINACEIDAE;
|
EID: 84896093907
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2014.03.003 Document Type: Short Survey |
Times cited : (5)
|
References (9)
|